Violation Tracker Individual Record
Date:January 30, 2012
Offense Group:competition-related offenses
Primary Offense:price-fixing or anti-competitive practices
Ferring and Aventis agreed to pay a total of $3.45 million to settle multistate litigation claiming they engaged in anti-competitive actions with regard to the sale of the drug DDAVP.
Level of Government:state
Action Type:agency action
Agency:Multistate Attorneys General Case
Civil or Criminal Case:civil
Link to Archived Court Document:
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.